BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly

NEXT STORY
BioCryst Presents Data Showing Sustained Attack Rate Reductions, Improved Patient Satisfaction and Quality of Life for HAE Patients Taking Berotralstat in APeX-2 Trial
PREV STORY
Madrigal Pharmaceuticals Highlights Presentations at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting November 13, 2020, Including NASH Expert Insights on the Ongoing Open Label Arm of Resmetirom 52-Week Phase 3 MAESTRO-NAFLD-1 Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

author_avatar
NASDAQ Market News

Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma

author_avatar
NASDAQ Market News

Aptose Reports Results for the First Quarter Ended March 31, 2018

Conference Call and Webcast at 5pm EDT TodaySAN DIEGO and TORONTO, May 10, 2018 ...

author_avatar
NASDAQ Market News